SXRN Injection

· Jiangsu Nutai Biologics Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SXRN Injection, covering 2025-12-08 to 2025-12-08. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics, and Preliminary Efficacy of SXRN Injection in Patients With Cancer Cachexia [Phase 1]

See pricing